Prossimo Advisors’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,294
Closed -$357K 46
2025
Q2
$357K Sell
1,294
-85
-6% -$23.1K 0.29% 87
2025
Q1
$366K Buy
1,379
+6
+0.4% +$1.48K 0.28% 103
2024
Q4
$319K Buy
1,373
+8
+0.6% +$1.84K 0.23% 111
2024
Q3
$301K Buy
1,365
+40
+3% +$8.28K 0.22% 116
2024
Q2
$260K Buy
1,325
+10
+0.8% +$2.07K 0.24% 113
2024
Q1
$283K Buy
1,315
+145
+12% +$30.5K 0.55% 52
2023
Q4
$246K Buy
1,170
+20
+2% +$4.27K 0.52% 54
2023
Q3
$230K Hold
1,150
0.54% 52
2023
Q2
$213K Sell
1,150
-10
-0.9% -$1.85K 0.21% 118
2023
Q1
$222K Sell
1,160
-1,280
-52% -$231K 0.54% 51
2022
Q4
$410K Buy
+2,440
New +$424K 0.95% 38

Other funds holding CME

Prossimo Advisors's CME Position: Q3 2025 in Review

Prossimo Advisors sold out of CME Group (CME) in Q3 2025, closing a stake of 1,294 shares — an estimated $357K sold.

Prossimo Advisors first reported a position in CME in Q4 2022 and held it in 11 quarters. The position peaked at $410K in Q4 2022. 1,653 funds tracked by Wall St. Rank hold CME as of Q3 2025.

  • Prossimo Advisors reported no remaining CME Group position as of Q3 2025 after selling out during the quarter.
  • Prossimo Advisors sold 1,294 CME Group shares in Q3 2025, an estimated $357K.
  • Prossimo Advisors first reported a position in CME Group in Q4 2022 and held it in 11 quarters.
  • Prossimo Advisors's CME Group position peaked at $410K in Q4 2022.
  • 1,653 funds tracked by Wall St. Rank held CME Group as of Q3 2025.

Based on Prossimo Advisors's 13F filing for Q3 2025, filed 28 Oct 2025.